temocillin has been researched along with meropenem in 12 studies
Studies (temocillin) | Trials (temocillin) | Recent Studies (post-2010) (temocillin) | Studies (meropenem) | Trials (meropenem) | Recent Studies (post-2010) (meropenem) |
---|---|---|---|---|---|
216 | 17 | 78 | 3,803 | 284 | 2,253 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Docquier, JD; Frère, JM; Rossolini, GM; Stoczko, M | 1 |
De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
Borgianni, L; Docquier, JD; Hanson, ND; Prandi, S; Rossolini, GM; Salden, L; Santella, G | 1 |
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
Giamarellou, H | 1 |
Apfalter, P; Hartl, R; Kerschner, H; Widhalm, S | 1 |
Cantón, R; Costa-de-Oliveira, S; Espinar, MJ; Faria-Ramos, I; Miranda, IM; Pina-Vaz, C; Ricardo, E; Rodrigues, AG; Silva, AP | 1 |
Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J | 1 |
Flach, CF; Kotsakis, SD; Larsson, DGJ; Razavi, M | 1 |
Hanssens, L; Sputael, V; Van Schandevyl, G | 1 |
Hopkins, KL; Meunier, D; Mustafa, N; Pike, R; Woodford, N | 1 |
Barrera Pulido, L; Borreguero Borreguero, I; Bustos de Godoy, N; Camean-Fernández, M; Gutiérrez-Gutiérrez, B; León, MJ; López-Cerero, L; López-Cortés, LE; Marín-Candón, A; Merino, V; Pascual, A; Retamar, P; Rodriguez-Baño, J; Rosso-Fernández, CM; Salamanca, E | 1 |
1 review(s) available for temocillin and meropenem
Article | Year |
---|---|
beta-Lactams without a suicide inhibitor.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2008 |
1 trial(s) available for temocillin and meropenem
Article | Year |
---|---|
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant
Topics: Bacteremia; Cephalosporins; Clinical Trials, Phase III as Topic; Enterobacteriaceae; Humans; Meropenem; Multicenter Studies as Topic; Penicillins; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic | 2021 |
10 other study(ies) available for temocillin and meropenem
Article | Year |
---|---|
Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Molecular Sequence Data; Open Reading Frames; Pectobacterium carotovorum; Phenotype; Phylogeny; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.
Topics: Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Meropenem; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Pseudomonas aeruginosa; Sequence Homology, Amino Acid; Thienamycins; United States | 2011 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2013 |
Rapid Flow Cytometry Test for Identification of Different Carbapenemases in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Boronic Acids; Cloxacillin; Edetic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Humans; Meropenem; Penicillins; Thienamycins | 2016 |
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin | 2017 |
Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalytic Domain; Cefoxitin; Cloning, Molecular; Enterobacteriaceae; Gene Expression; Hospitals; Humans; Hydrolysis; Isoenzymes; Kinetics; Meropenem; Microbial Sensitivity Tests; Models, Molecular; Oxacillin; Penicillins; Plasmids; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Recombinant Proteins; Substrate Specificity; Wastewater | 2019 |
A case report of successful eradication of new isolates of
Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Child, Preschool; Cystic Fibrosis; Humans; Levofloxacin; Male; Maxillary Sinus; Maxillary Sinusitis; Meropenem; Nasal Lavage; Otorhinolaryngologic Surgical Procedures; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Evaluation of temocillin and meropenem MICs as diagnostic markers for OXA-48-like carbapenemases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biomarkers; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genes, MDR; Meropenem; Microbial Sensitivity Tests; Penicillins; Whole Genome Sequencing | 2019 |